An Eli Lilly spokesperson provided this statement: Lilly is committed to making life better for people living with diabetes and obesity through developing medicines like Mounjaro and Zepbound that change the way healthcare providers can treat these diseases
Mounjaro has shown strong weight loss results in clinical trials and is approved for type 2 diabetes
Li Y, Teng Y, Huang Y, Huang L, Yang S, Liu J, Zou H, Xie Y
Transforming growth factor-beta signaling across ages: from distorted lung development to chronic obstructive pulmonary disease
The impact of this drought, considered atypical by local authorities, goes beyond the environment, deeply affecting peoples lives
doi: 10.1016/j.tem.2023.03.002 150 KnightRWalkerVIpSCooperJBoltonTKeeneSet al